Palisade Bio, Inc. (PALI)
1.95
-0.06
(-2.99%)
USD |
NASDAQ |
May 22, 16:00
1.94
-0.01
(-0.51%)
After-Hours: 20:00
Palisade Bio Shareholders Equity (Quarterly) : 127.36M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 390.32M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
| Savara, Inc. | 176.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 133.32M |
| Total Liabilities (Quarterly) | 5.953M |
| Current Ratio | 23.71 |
| Net Debt Paydown Yield | 0.01% |